Kathryn Haviland
Overview
Kathryn Haviland received an average of $2M in total compensation, including $410K in salary, at Blueprint Medicines from 2017 to 2020.
Source: SEC filings on April 21, 2021 and April 29, 2020.
Related executives
We found ten more executives who work or worked at Blueprint Medicines.
Fouad Namouni
Blueprint Medicines
President, Research and Development
Jeffrey Albers
Blueprint Medicines
Chief Executive Officer
Tracey McCain
Blueprint Medicines
Chief Legal and Compliance Officer
Michael Landsittel
Blueprint Medicines
Chief Financial Officer
Anthony Boral
Blueprint Medicines
Chief Medical Officer
Christina Rossi
Blueprint Medicines
Chief Commercial Officer
Christopher Murray
Blueprint Medicines
Senior Vice President, Technical Operations
Kate Haviland
Blueprint Medicines